DEA Schedule CIII
Strength
5 ug/h
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093365640
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
4/22/2026
Active Ingredients
BUPRENORPHINEApproval Type
Generic (ANDA)
FDA Application
ANDA204937On Market Since
11/26/2018
Pharmacological Classes
Partial Opioid Agonist
Partial Opioid Agonists
Related Drugs
Same classification
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
42858050103•Rhodes Pharmaceuticals L.P.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2676
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00121101830•PAI Holdings LLC
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00228315403•Actavis Pharma, Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00406800503•SpecGx LLC
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00904700906•Major Pharmaceuticals
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
16729054910•Accord Healthcare Inc.
$0.4698
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
42858060103•Rhodes Pharmaceuticals L.P.
$0.4698
per EA